February 27, 2020 / 12:44 PM / a month ago

BRIEF-Sage Therapeutics Reports Q4 Revenue Of $2 Mln

Feb 27 (Reuters) - SAGE Therapeutics Inc:

* SAGE THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND HIGHLIGHTS PIPELINE AND BUSINESS PROGRESS

* Q4 REVENUE ESTIMATE $3.7 MILLION — REFINITIV IBES DATA

* EVALUATING PATH FORWARD FOR ZURANOLONE (SAGE-217) LANDSCAPE PROGRAM

* EXPECTS ZULRESSO REVENUE GROWTH WILL BE MODEST OVER NEXT COUPLE OF QUARTERS

* SEES AN INCREASE IN RATE OF GROWTH OF ZULRESSO REVENUE ANTICIPATED IN SECOND HALF OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below